| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
149,833 |
273,514 |
403,791 |
783,386 |
| Total Sell Value |
$57,803,893 |
$105,302,123 |
$145,030,198 |
$240,508,832 |
| Total People Sold |
7 |
10 |
12 |
12 |
| Total Sell Transactions |
21 |
34 |
49 |
76 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2019-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,799 |
4,472 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2019-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(744) |
3,173 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,978) |
12,553 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,987 |
13,483 |
|
- |
|
| Rosa David J. |
EVP & Chief Commercial Officer |
• – – |
2019-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,337) |
12,164 |
|
- |
|
| Rosa David J. |
EVP & Chief Commercial Officer |
• – – |
2019-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,711 |
13,292 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2019-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,963) |
356,033 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2019-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,974 |
357,322 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-02-15 |
4/A |
D |
$548.50 |
$533,142 |
D/D |
(972) |
10,626 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-02-15 |
4/A |
OE |
$0.00 |
$0 |
D/D |
1,959 |
11,598 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-02-15 |
4 |
D |
$548.50 |
$1,074,512 |
D/D |
(1,959) |
10,546 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,959 |
11,518 |
|
- |
|
| Rosa David J. |
EVP & Chief Commercial Officer |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,106) |
9,790 |
|
- |
|
| Rosa David J. |
EVP & Chief Commercial Officer |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,542 |
10,896 |
|
- |
|
| Samath Jamie |
VP & Principal Accounting Offi |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(265) |
577 |
|
- |
|
| Samath Jamie |
VP & Principal Accounting Offi |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
763 |
842 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(645) |
2,417 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,695) |
353,022 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,417 |
354,717 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(808) |
3,062 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
3,870 |
|
- |
|
| Brogna Salvatore |
EVP & Chief Operating Officer |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,112) |
2,917 |
|
- |
|
| Brogna Salvatore |
EVP & Chief Operating Officer |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,542 |
3,434 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2019-02-15 |
4 |
D |
$521.95 |
$235,676 |
D/D |
(441) |
4,460 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,113 |
4,667 |
|
- |
|
1324 Records found
|
|
Page 26 of 53 |
|
|
5.92 (1.56%) 
